BioLineRx Ltd. Equity
BioLineRx Ltd. (BLRX) had Equity of $23.34 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-03-23
- 2025-12-31: Equity $23.34M.
- 2025-06-30: Equity $20.07M.
- 2024-12-31: Equity $13.46M.
- 2024-06-30: Equity $13.89M; Equity as first filed $13.98M.
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2025-12-31 | $23.34M 20-F · filed 2026-03-23 | |
| 2025-06-30 | $20.07M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $13.46M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $13.89M 6-K · filed 2025-08-14 | $13.98M 6-K · filed 2024-08-15 |
| 2023-12-31 | $13.22M 20-F · filed 2026-03-23 | |
| 2023-06-30 | $21.05M 6-K · filed 2024-08-15 | |
| 2022-12-31 | $50.84M 20-F · filed 2026-03-23 | |
| 2022-06-30 | $56.57M 6-K · filed 2023-08-30 | |
| 2022-03-31 | $63.41M 6-K · filed 2022-08-16 | |
| 2021-12-31 | $68.09M 20-F · filed 2025-03-31 | |
| 2021-06-30 | $73.89M 6-K · filed 2022-08-16 | |
| 2021-03-31 | $64.65M 6-K · filed 2022-08-16 | |
| 2020-12-31 | $22.03M 20-F · filed 2024-03-26 | |
| 2020-06-30 | $29.23M 6-K · filed 2021-08-18 | |
| 2020-03-31 | $28.51M 6-K · filed 2021-08-18 | |
| 2019-12-31 | $33.38M 20-F · filed 2023-03-22 | |
| 2019-06-30 | $41.78M 6-K · filed 2020-08-06 | |
| 2019-03-31 | $45.89M 6-K · filed 2020-08-06 | |
| 2018-12-31 | $41.32M 20-F · filed 2022-03-16 | |
| 2018-06-30 | $46.19M 6-K · filed 2019-08-06 | |
| 2017-12-31 | $52.88M 20-F · filed 2021-02-23 | |
| 2017-06-30 | $57.43M 6-K · filed 2018-08-13 | |
| 2016-12-31 | $35.03M 20-F · filed 2020-03-12 | |
| 2015-12-31 | $47.61M 20-F · filed 2019-03-28 | |
| 2014-12-31 | $31.80M 20-F · filed 2018-03-06 |